To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Non-Departmental Publication (News and Communications)
Competition and Markets Authority

Oct. 12 2022

Source Page: Private healthcare market investigation
Document: Appendices and Glossary (PDF, 1.9 Mb) (PDF)

Found: A2(1) -14 (d) a full cancer service including radiotherapy. 21 43.

Written Question
Cancer: Medical Treatments
Tuesday 19th July 2022

Asked by: Greg Smith (Conservative - Buckingham)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) clinical and (b) patient awareness of minimally invasive cancer therapies as outlined in the All-party parliamentary group on Minimally Invasive Cancer Therapies' recent report, Barriers to Patient Access.

Answered by James Morris

The All-Party Parliamentary Group’s report refers to a number of treatments which are not directly commissioned by NHS England and NHS Improvement. Where the National Institute for Health and Care Excellence has recommended a treatment following a technology appraisal, commissioners have a mandate to support implementation, including providing funding pathways where necessary.

For those treatments cited in the report which have received a positive technology appraisal, such as the use of selective internal radiation therapy (SIRT) to treat hepatocellular carcinoma, NHS England and NHS Improvement’s specialised commissioning team is currently expanding the number of providers. This involves a Prior Information Notice and market engagement exercise, which is due to be completed in 2022/23, before a service can be delegated to integrated care boards.

Written Question
Cancer: Medical Treatments
Tuesday 19th July 2022

Asked by: Greg Smith (Conservative - Buckingham)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department plans to take steps to implement the recommendations of the recently published report of the All-party parliamentary group on Minimally Invasive Cancer Therapies, Barriers to Patient Access; and if he will make a statement.

Answered by James Morris

The All-Party Parliamentary Group’s report refers to a number of treatments which are not directly commissioned by NHS England and NHS Improvement. Where the National Institute for Health and Care Excellence has recommended a treatment following a technology appraisal, commissioners have a mandate to support implementation, including providing funding pathways where necessary.

For those treatments cited in the report which have received a positive technology appraisal, such as the use of selective internal radiation therapy (SIRT) to treat hepatocellular carcinoma, NHS England and NHS Improvement’s specialised commissioning team is currently expanding the number of providers. This involves a Prior Information Notice and market engagement exercise, which is due to be completed in 2022/23, before a service can be delegated to integrated care boards.

Departmental Publication (Policy and Engagement)
Department of Health and Social Care

Jun. 27 2022

Source Page: Draft Mental Health Bill 2022
Document: Draft Mental Health Bill: impact assessment (PDF)

Found: receiving the majority of me dical treatments ( category 3 in the White Paper , which excludes invasive

Non-Departmental Publication (Guidance and Regulation)
Advisory Committee on Clinical Excellence Awards

Jun. 06 2022

Source Page: Personal statements from new award holders in the 2021 round
Document: Personal statements of new national Clinical Excellence Award recipients 2021 (PDF)

Found: Service Delivery : secured funding and introduced minimally invasive heart pumps to my trust, to prevent

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

May. 31 2022

Source Page: Freedom of Information responses from the MHRA - week commencing 14 February 2022
Document: FOI-22-394-2 (PDF)

Found: Dosing recommendations before and after invasive procedures and surgical intervention If an invasive

Select Committee
Royal College of Radiologists
 RTR0133 - Workforce: recruitment, training and retention in health and social care

Written Evidence Mar. 22 2022

Inquiry: Workforce: recruitment, training and retention in health and social care
Inquiry Status: Open
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)

Found: Similarly, it is estimated that 1 in 2 people in the UK will have cancer at some point in their lives2

Departmental Publication (Guidance and Regulation)
Department for Work and Pensions

Feb. 14 2022

Source Page: Medical guidance for DLA and AA decision makers (adult cases): staff guide
Document: Word version: Medical guidance for DLA and AA decision makers (adult cases): staff guide (webpage)

Found: after treatment for invasive bladder cancer - follow Advanced or Metastatic bladder cancer guidance

Departmental Publication (Statistics)
Department of Health and Social Care

Aug. 04 2021

Source Page: Radiological dose issues with interventional radiology in the UK
Document: Radiological dose issues with interventional radiology in the UK (PDF)

Found: In addition, many more conditions can be treated in a fast, efficient and minimally invasive manner,

Deposited Papers
Department for Business, Energy and Industrial Strategy

Jul. 30 2021

Source Page: I. R&D People and Culture Strategy: people at the heart of R&D. 39p. II. UK Innovation Strategy: leading the future by creating it. Incl. annexes. 116p.
Document: UK_Innovation_Strategy.pdf (PDF)

Found: of funding sources for R&D, including a wealth of resear ch charities such as the Wellcome Trust, Cancer